BackZiopharm Oncology Overview

Ziopharm Oncology Current Assets

Ziopharm Oncology's current assets is $670K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$666000.00
↓ 82.18% YoYΔ $-3.07M vs prior year quarter

Peer trimmed avg / median

Loading

Ziopharm Oncology Current Assets History

Loading

Ziopharm Oncology vs. peers: Current Assets Comparison

Loading

Ziopharm Oncology Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ziopharm Oncology (ZIOP) FAQ

As of the most recent data (June 2026), ZIOP shows a current assets of $670K. That compares with $3.7M in the prior-year period — down 82.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZIOP's current assets is now $670K (was $3.7M) — a 82.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ziopharm Oncology is outperforming or lagging.

Tracking ZIOP's current assets over time shows whether Ziopharm Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $670K That compares with $3.7M in the prior-year period — down 82.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Ziopharm Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $670K) with ownership activity and broader fundamentals.

Ziopharm Oncology's current assets is $670K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.